Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Healthy Adult Participants 1Breast Neoplasms 1

Interventions

pembrolizumab 609Carboplatin 373Paclitaxel 283Cisplatin 267Gemcitabine 257Pemetrexed 194Nivolumab 192Bevacizumab 191Docetaxel 190Injections 167Cyclophosphamide 147atezolizumab 137Capecitabine 134Fluorouracil 133Oxaliplatin 132Dexamethasone 130Fulvestrant 115durvalumab 114130-nm albumin-bound paclitaxel 110fludarabine 100Cetuximab 100Rituximab 96Leucovorin 96venetoclax 89Lenalidomide 84enzalutamide 79Prednisone 79Ipilimumab 75Azacitidine 75Irinotecan 74

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Bupropion × 1 year × Clear all
NCT05646862 2026-05-06

INAVO121

Hoffmann-La Roche

Phase 3 Active not recruiting
420 enrolled
Breast

Breast Neoplasms

NCT07235748 2026-02-17

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

Servier

Phase 1 Completed
28 enrolled

Healthy Adult Participants

Data powered by HemOnc (CC BY 4.0) Colophon âš¡